Ready To Ship Anti-west Nile Virus(wnv)(lineage 1, Strain Ny99) E/envelope(domain Iii) Monoclonal Antibody Holiday Edition [sSdw4fKo]

Anti-West Nile Virus (WNV) Monoclonal Antibody: Your Ultimate Defense

Introducing our cutting-edge Anti-West Nile Virus (WNV) Monoclonal Antibody, a powerful tool designed to combat the West Nile Virus (WNV) effectively. This monoclonal antibody is specifically engineered to target the E/Envelope (Domain III) of the WNV, ensuring a precise and targeted approach to viral inhibition. With its high specificity and affinity, this antibody is your ultimate defense against the WNV, providing you with peace of mind and reliable protection.

Product Specifications and Technical Details

Our Anti-West Nile Virus Monoclonal Antibody is produced in mice and isolated using Protein A Affinity Chromatography, ensuring purity and consistency. The antibody is conjugated to IgG1 isotype and is available in a concentration of 1 mg/mL in PBS buffer. The immunogen used for the production of this antibody is recombinant WNV (lineage 1, strain NY99) E/Envelope Protein (Domain III, His Tag), guaranteeing its effectiveness against the specific strain of WNV. This monoclonal antibody is ideal for use in ELISA applications, where it demonstrates high sensitivity and specificity.

Practical Applications and Target Audience

Our Anti-West Nile Virus Monoclonal Antibody is a valuable asset for researchers and healthcare professionals involved in the study and treatment of WNV infections. Its applications in ELISA make it an essential tool for diagnostic testing, as well as for the development of vaccines and therapeutic agents. With its high purity, specificity, and stability, this antibody is suitable for use in various research settings, including laboratories, medical facilities, and research institutions. By using our Anti-West Nile Virus Monoclonal Antibody, you can contribute to the advancement of WNV research and improve patient care.